Understanding early immune responses to SARS-CoV-2 infections
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
This study is looking at how the immune system reacts right after someone is exposed to the COVID-19 virus, by tracking people who have been near confirmed cases to see how their bodies respond before they show any symptoms, helping us understand how to better protect against the virus and what might help with long-term immunity.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10680626 on NIH RePORTER |
What this research studies
This research investigates how the immune system responds to SARS-CoV-2 infections, particularly focusing on the early immune events that occur immediately after exposure to the virus. By following individuals who have been in close contact with confirmed COVID-19 cases, the study aims to analyze blood and oral samples to identify the types of immune responses that develop before symptoms appear. The research will explore the role of specific immune cells and antibodies in providing protection against the virus and how these responses may influence long-term immunity.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who have been in close contact with someone diagnosed with COVID-19, especially those who remain asymptomatic.
Not a fit: Patients who have not been exposed to SARS-CoV-2 or those with pre-existing severe immune deficiencies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of how to enhance immune responses against SARS-CoV-2, potentially informing vaccine development and treatment strategies.
How similar studies have performed: Other research has shown promising results in understanding immune responses to viral infections, but this specific focus on early immunity to SARS-CoV-2 is relatively novel.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: King, Christopher L — Case Western Reserve University
- Study coordinator: King, Christopher L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.